Table 3 Baseline characteristics associated with elevated blood 25-hydroxyvitamin D (> 60 ng/mL versus ≤ 60 ng/mL) by univariable logistic regression

Age (years)

1.03

0.99–1.06

0.141

Sex

 Male

1 (Reference)

 Female

1.90

0.70–5.18

0.208

Marital status

 Single

1 (Reference)

 Married

2.46

0.65–9.34

0.186

 Divorced

1.47

0.15–14.33

0.739

 Widowed

4.65

1.02–21.08

0.046

 Unknown

1.46

0.15–14.17

0.746

Ethnicity

2.46

0.65–9.34

0.186

 White

1 (Reference)

 Black/African American

0.99

0.28–3.50

0.983

 Hispanic/Latino

-

-

-

 Asian

-

-

-

 Other/Unknown

0.28

0.04–2.18

0.225

Type of intensive care unit

 Medical Intensive Care Unit

1 (Reference)

 Medical/Surgical Intensive Care Unit

3.18

0.58–17.51

0.183

 Cardiac Vascular Intensive Care Unit

10.87

1.78–66.62

0.010

 Surgical Intensive Care Unit

3.18

0.53–19.18

0.208

 Trauma Surgical Intensive Care Unit

3.77

0.52–27.10

0.187

 Coronary Care Unit

6.58

1.08–39.96

0.041

 Neuro Surgical Intensive Care Unit

–

–

–

 Neuro Intermediate

–

–

–

 Neuro Stepdown

–

–

–

 Post-anesthesia Care Unit

–

–

–

Glasgow Coma Scale

1.00

0.88–1.15

0.950

SOFA

1.02

0.92–1.13

0.741

SAPS II

1.01

0.98–1.05

0.452

Charlson Comorbidity Index

1.09

0.94–1.27

0.238

Comorbidities^$

 Myocardial infarction

1.84

0.59–5.71

0.293

 Congestive heart failure

0.44

0.13–1.55

0.201

 Peripheral vascular disease

1.24

0.28–5.51

0.774

 Chronic pulmonary disease

1.28

0.45–3.66

0.647

 Mild liver disease

1.47

0.54–4.02

0.448

 Severe liver disease

0.86

0.25–3.02

0.816

 Renal disease

2.15

0.82–5.62

0.119

 Dialysis

1.22

0.35–4.28

0.761

 Diabetes without complications

0.67

0.19–2.34

0.528

 Diabetes with complications

1.59

0.51–4.94

0.421

 Cerebrovascular disease

1.09

0.25–4.83

0.909

 Dementia

1.40

0.18–10.76

0.748

 Paraplegia

1.54

0.20–11.85

0.681

 Rheumatic disease

–

–

–

 Malignant tumor

1.54

0.50–4.77

0.456

 Acquired immunodeficiency syndrome

–

–

–